PERUTELLI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 404
EU - Europa 158
AS - Asia 136
AF - Africa 2
SA - Sud America 1
Totale 701
Nazione #
US - Stati Uniti d'America 402
SG - Singapore 60
IT - Italia 52
CN - Cina 49
IE - Irlanda 38
SE - Svezia 26
FI - Finlandia 13
UA - Ucraina 9
HK - Hong Kong 6
ID - Indonesia 6
IN - India 6
FR - Francia 4
PL - Polonia 4
BY - Bielorussia 3
DE - Germania 3
KR - Corea 3
CA - Canada 2
NG - Nigeria 2
RO - Romania 2
VN - Vietnam 2
AR - Argentina 1
AT - Austria 1
BE - Belgio 1
GB - Regno Unito 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
TR - Turchia 1
Totale 701
Città #
Santa Clara 78
Chandler 76
Singapore 52
Dublin 38
Turin 15
Fairfield 14
Nyköping 14
Ashburn 13
Columbus 12
Helsinki 12
Houston 9
Beijing 8
Hangzhou 8
New York 8
Princeton 8
Guangzhou 7
Medford 7
Ann Arbor 6
Jakarta 6
Torino 6
Chennai 5
Hong Kong 5
Seattle 5
Bologna 4
Boston 4
Cambridge 4
Canelli 4
Guiyang 4
San Diego 4
San Mateo 4
Warsaw 4
Wilmington 4
Redwood City 3
Seoul 3
Abuja 2
Chieri 2
Fremont 2
Hebei 2
Los Angeles 2
Munich 2
Nanjing 2
Naples 2
Norwalk 2
Rome 2
Upper Marlboro 2
Washington 2
Aiello Del Sabato 1
Brussels 1
Buenos Aires 1
Chengdu 1
Chicago 1
Dongguan 1
Droitwich 1
East Brunswick 1
Falkenstein 1
Fort Collins 1
Grugliasco 1
Izmir 1
Jacksonville 1
Jinan 1
Lappeenranta 1
Milan 1
Montreal 1
Pune 1
Toronto 1
Venezia 1
Vienna 1
Woodbridge 1
Totale 500
Nome #
Pre-existing and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs 108
Real life use of bendamustine in elderly patients with lymphoid neoplasia 100
Targeting hif-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll 79
Modulation of Phenotypic and Functional Features of Immune Cells in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib 74
Cd200 baseline serum levels predict prognosis of chronic lymphocytic leukemia 73
Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia 63
Impact of immune parameters and immune dysfunctions on the prognosis of patients with chronic lymphocytic leukemia 60
Immunotherapeutic strategies in chronic lymphocytic leukemia: advances and challenges 52
Beyond ibrutinib: novel BTK inhibitors for the treatment of chronic lymphocytic leukemia 35
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia 30
CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep? 26
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 23
Totale 723
Categoria #
all - tutte 3.034
article - articoli 0
book - libri 0
conference - conferenze 276
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.310


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202177 0 0 0 4 13 3 9 6 12 2 1 27
2021/2022142 8 7 14 7 11 2 10 4 5 13 34 27
2022/2023189 20 19 2 15 15 49 14 12 24 5 5 9
2023/2024101 13 17 7 4 3 25 0 6 1 7 7 11
2024/2025214 4 13 14 41 97 45 0 0 0 0 0 0
Totale 723